China Prostate-Specific Antigen (PSA) Test Market Report & Forecast 2021-2027

Publisher Name :
Date: 18-Nov-2021
No. of pages: 93
Inquire Before Buying

China Prostate-Specific Antigen (PSA) Test Market, By Type, 2016-2021, 2022-2027 ($ Millions)

China Prostate-Specific Antigen (PSA) Test Market Segment Percentages, By Type, 2020 (%)

- CLIA

- ELISA

- Other

China Prostate-Specific Antigen (PSA) Test Market, By Application, 2016-2021, 2022-2027 ($ Millions)

China Prostate-Specific Antigen (PSA) Test Market Segment Percentages, By Application, 2020 (%)

- Screening

- Post-treatment Monitoring

- Other

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Prostate-Specific Antigen (PSA) Test revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Prostate-Specific Antigen (PSA) Test revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Abbott

- Siemens Healthcare

- DiaSorin

- Roche

- Beckman Coulter

- PerkinElmer

- Tosoh

- Ortho Clinical

- Fujirebio

- Mediwatch (LABORIE)

- BodiTech

China Prostate-Specific Antigen (PSA) Test Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Prostate-Specific Antigen (PSA) Test Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Prostate-Specific Antigen (PSA) Test Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Prostate-Specific Antigen (PSA) Test Overall Market Size
2.1 China Prostate-Specific Antigen (PSA) Test Market Size: 2021 VS 2027
2.2 China Prostate-Specific Antigen (PSA) Test Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate-Specific Antigen (PSA) Test Players in China Market
3.2 Top China Prostate-Specific Antigen (PSA) Test Companies Ranked by Revenue
3.3 China Prostate-Specific Antigen (PSA) Test Revenue by Companies
3.4 Top 3 and Top 5 Prostate-Specific Antigen (PSA) Test Companies in China Market, by Revenue in 2020
3.5 Companies Prostate-Specific Antigen (PSA) Test Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate-Specific Antigen (PSA) Test Players in China Market
3.6.1 List of Tier 1 Prostate-Specific Antigen (PSA) Test Companies in China
3.6.2 List of Tier 2 and Tier 3 Prostate-Specific Antigen (PSA) Test Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Prostate-Specific Antigen (PSA) Test Market Size Markets, 2021 & 2027
4.1.2 CLIA
4.1.3 ELISA
4.1.4 Other
4.2 By Type - China Prostate-Specific Antigen (PSA) Test Revenue & Forecasts
4.2.1 By Type - China Prostate-Specific Antigen (PSA) Test Revenue, 2016-2021
4.2.2 By Type - China Prostate-Specific Antigen (PSA) Test Revenue, 2022-2027
4.2.3 By Type - China Prostate-Specific Antigen (PSA) Test Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Prostate-Specific Antigen (PSA) Test Market Size, 2021 & 2027
5.1.2 Screening
5.1.3 Post-treatment Monitoring
5.1.4 Other
5.2 By Application - China Prostate-Specific Antigen (PSA) Test Revenue & Forecasts
5.2.1 By Application - China Prostate-Specific Antigen (PSA) Test Revenue, 2016-2021
5.2.2 By Application - China Prostate-Specific Antigen (PSA) Test Revenue, 2022-2027
5.2.3 By Application - China Prostate-Specific Antigen (PSA) Test Revenue Market Share, 2016-2027
6 Prostate-Specific Antigen (PSA) Test Companies Profiles
6.1 Abbott
6.1.1 Abbott Company Details
6.1.2 Abbott Business Overview
6.1.3 Abbott Prostate-Specific Antigen (PSA) Test Introduction
6.1.4 Abbott Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021)
6.1.5 Abbott Recent Developments
6.2 Siemens Healthcare
6.2.1 Siemens Healthcare Company Details
6.2.2 Siemens Healthcare Business Overview
6.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Introduction
6.2.4 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021)
6.2.5 Siemens Healthcare Recent Developments
6.3 DiaSorin
6.3.1 DiaSorin Company Details
6.3.2 DiaSorin Business Overview
6.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Introduction
6.3.4 DiaSorin Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021)
6.3.5 DiaSorin Recent Developments
6.4 Roche
6.4.1 Roche Company Details
6.4.2 Roche Business Overview
6.4.3 Roche Prostate-Specific Antigen (PSA) Test Introduction
6.4.4 Roche Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021)
6.4.5 Roche Recent Developments
6.5 Beckman Coulter
6.5.1 Beckman Coulter Company Details
6.5.2 Beckman Coulter Business Overview
6.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Introduction
6.5.4 Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021)
6.5.5 Beckman Coulter Recent Developments
6.6 PerkinElmer
6.6.1 PerkinElmer Company Details
6.6.2 PerkinElmer Business Overview
6.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Introduction
6.6.4 PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021)
6.6.5 PerkinElmer Recent Developments
6.7 Tosoh
6.7.1 Tosoh Company Details
6.7.2 Tosoh Business Overview
6.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Introduction
6.7.4 Tosoh Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021)
6.7.5 Tosoh Recent Developments
6.8 Ortho Clinical
6.8.1 Ortho Clinical Company Details
6.8.2 Ortho Clinical Business Overview
6.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Introduction
6.8.4 Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021)
6.8.5 Ortho Clinical Recent Developments
6.9 Fujirebio
6.9.1 Fujirebio Company Details
6.9.2 Fujirebio Business Overview
6.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Introduction
6.9.4 Fujirebio Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021)
6.9.5 Fujirebio Recent Developments
6.10 Mediwatch (LABORIE)
6.10.1 Mediwatch (LABORIE) Company Details
6.10.2 Mediwatch (LABORIE) Business Overview
6.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Introduction
6.10.4 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021)
6.10.5 Mediwatch (LABORIE) Recent Developments
6.11 BodiTech
6.11.1 BodiTech Company Details
6.11.2 BodiTech Business Overview
6.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Introduction
6.11.4 BodiTech Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021)
6.11.5 BodiTech Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Prostate-Specific Antigen (PSA) Test Market Opportunities & Trends in China Market
Table 2. Prostate-Specific Antigen (PSA) Test Market Drivers in China Market
Table 3. Prostate-Specific Antigen (PSA) Test Market Restraints in China Market
Table 4. Key Players of Prostate-Specific Antigen (PSA) Test in China Market
Table 5. Top Prostate-Specific Antigen (PSA) Test Players in China Market, Ranking by Revenue (2019)
Table 6. China Prostate-Specific Antigen (PSA) Test Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Prostate-Specific Antigen (PSA) Test Revenue Share by Companies, 2016-2021
Table 8. Companies Prostate-Specific Antigen (PSA) Test Product Type
Table 9. List of Tier 1 Prostate-Specific Antigen (PSA) Test Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Prostate-Specific Antigen (PSA) Test Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Prostate-Specific Antigen (PSA) Test Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Prostate-Specific Antigen (PSA) Test Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Prostate-Specific Antigen (PSA) Test Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Prostate-Specific Antigen (PSA) Test Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Prostate-Specific Antigen (PSA) Test Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Prostate-Specific Antigen (PSA) Test Revenue (US$, Mn), 2022-2027
Table 17. Abbott Company Details
Table 18. Abbott Business Overview
Table 19. Abbott Prostate-Specific Antigen (PSA) Test Product
Table 20. Abbott Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Abbott Recent Developments
Table 22. Siemens Healthcare Company Details
Table 23. Siemens Healthcare Business Overview
Table 24. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product
Table 25. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Siemens Healthcare Recent Developments
Table 27. DiaSorin Company Details
Table 28. DiaSorin Business Overview
Table 29. DiaSorin Prostate-Specific Antigen (PSA) Test Product
Table 30. DiaSorin Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021) & (US$ Million)
Table 31. DiaSorin Recent Developments
Table 32. Roche Company Details
Table 33. Roche Business Overview
Table 34. Roche Prostate-Specific Antigen (PSA) Test Product
Table 35. Roche Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Roche Recent Developments
Table 37. Beckman Coulter Company Details
Table 38. Beckman Coulter Business Overview
Table 39. Beckman Coulter Prostate-Specific Antigen (PSA) Test Product
Table 40. Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Beckman Coulter Recent Developments
Table 42. PerkinElmer Company Details
Table 43. PerkinElmer Business Overview
Table 44. PerkinElmer Prostate-Specific Antigen (PSA) Test Product
Table 45. PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021) & (US$ Million)
Table 46. PerkinElmer Recent Developments
Table 47. Tosoh Company Details
Table 48. Tosoh Business Overview
Table 49. Tosoh Prostate-Specific Antigen (PSA) Test Product
Table 50. Tosoh Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Tosoh Recent Developments
Table 52. Ortho Clinical Company Details
Table 53. Ortho Clinical Business Overview
Table 54. Ortho Clinical Prostate-Specific Antigen (PSA) Test Product
Table 55. Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Ortho Clinical Recent Developments
Table 57. Fujirebio Company Details
Table 58. Fujirebio Business Overview
Table 59. Fujirebio Prostate-Specific Antigen (PSA) Test Product
Table 60. Fujirebio Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Fujirebio Recent Developments
Table 62. Mediwatch (LABORIE) Company Details
Table 63. Mediwatch (LABORIE) Business Overview
Table 64. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product
Table 65. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021) & (US$ Million)
Table 66. Mediwatch (LABORIE) Recent Developments
Table 67. BodiTech Company Details
Table 68. BodiTech Business Overview
Table 69. BodiTech Prostate-Specific Antigen (PSA) Test Product
Table 70. BodiTech Prostate-Specific Antigen (PSA) Test Revenue in China Market (2016-2021) & (US$ Million)
Table 71. BodiTech Recent Developments
List of Figures
Figure 1. Prostate-Specific Antigen (PSA) Test Segment by Type
Figure 2. Prostate-Specific Antigen (PSA) Test Segment by Application
Figure 3. China Prostate-Specific Antigen (PSA) Test Market Overview: 2020
Figure 4. China Prostate-Specific Antigen (PSA) Test Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Prostate-Specific Antigen (PSA) Test Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Prostate-Specific Antigen (PSA) Test Revenue in 2020
Figure 7. By Type - China Prostate-Specific Antigen (PSA) Test Revenue Market Share, 2016-2027
Figure 8. By Application - China Prostate-Specific Antigen (PSA) Test Revenue Market Share, 2016-2027
Figure 9. Abbott Prostate-Specific Antigen (PSA) Test Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. DiaSorin Prostate-Specific Antigen (PSA) Test Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Roche Prostate-Specific Antigen (PSA) Test Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Tosoh Prostate-Specific Antigen (PSA) Test Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Fujirebio Prostate-Specific Antigen (PSA) Test Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. BodiTech Prostate-Specific Antigen (PSA) Test Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs